CEVE stock plunged -99.50% to USD 0.0002 on 03 Mar 2026 during market hours, making it one of the top losers on the PNK exchange in the United States. The move followed a one-day drop from a previous close of USD 0.0401 and came on thin volume of 420 shares. This extreme decline highlights acute liquidity risk for Ceres Ventures, Inc. (CEVE) and signals possible corporate action, quote error, or market re-pricing. We use Meyka AI-powered market analysis to connect the price swing to fundamentals, technicals, and a short-term outlook for traders

CEVE stock: Price action and volume

CEVE stock traded at USD 0.0002 on 03 Mar 2026 after falling -99.50% in one session. Volume was 420 versus an average volume of 19, producing a relative volume of 22.11, which shows the move occurred on unusual but still small absolute liquidity. The large gap from the previous close of USD 0.0401 suggests a material corporate change, market repricing, or reporting/quote adjustment rather than ordinary intraday selling

CEVE stock: Business profile and sector context

Ceres Ventures, Inc. (CEVE) is listed on the PNK exchange in the United States and operates in Healthcare, industry Medical – Care Facilities, with technologies for water, soil, and air remediation. The company reports development-stage operations, limited employees, and no recent earnings announcements. Sector peers in clean technology and small-cap healthcare generally trade with far higher liquidity and revenue visibility, increasing relative risk for CEVE stock investors

CEVE stock: Fundamentals, ratios and red flags

Key fundamentals show a market cap of USD 17,100, shares outstanding 85,501,557, and no published EPS or PE ratio. Financial ratios include a current ratio of 0.21, negative book value per share, and operating cash flow per share -0.00 (TTM). These metrics point to a development-stage microcap with weak liquidity and sizeable leverage in relation to equity. Analysts would flag the tiny market cap and negative working capital as primary risks for CEVE stock

CEVE stock: Technicals and trading profile

Technical indicators for CEVE stock show an RSI near 48.35 and an ADX of 32.69, indicating trend strength on very low-priced data. Price averages are tiny: 50-day average USD 0.00010 and 200-day average USD 0.00011. The prior session’s collapse and the microcap structure create high volatility and thin order books, which can amplify price moves and widen spreads for CEVE stock traders

Meyka AI grade and CEVE stock forecast

Meyka AI rates CEVE with a score of 65.32 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry comparisons, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth. Meyka AI’s forecast model projects a 1-year price of USD 0.00008 and a 5-year price of USD 0.00044. Compared with the current price of USD 0.0002, the 1-year projection implies an expected -61.93% move, while the 5-year projection implies +120.52% upside. Forecasts are model-based projections and not guarantees

CEVE stock: Risks, catalyst and trading strategy

Primary risks for CEVE stock are extremely low liquidity, microcap market structure, negative working capital, and limited public filings or earnings history. Catalysts to monitor: any SEC filings, corporate press releases, financing announcements, or partnerships that validate BluFlow technologies. For traders, a cautious approach is to wait for confirmed corporate disclosures or materially higher volume before initiating positions in CEVE stock

Final Thoughts

CEVE stock’s dramatic drop to USD 0.0002 on 03 Mar 2026 underscores the dangers of microcap, OTC trading on the PNK exchange in the United States. The stock’s market cap of USD 17,100, thin daily volume, and negative working capital make short-term moves highly driven by liquidity and news flow rather than fundamentals. Meyka AI’s forecast model projects a 1-year target of USD 0.00008 (implying -61.93% from today) and a 5-year target of USD 0.00044 (implying +120.52% upside). These model outputs show asymmetric scenarios: near-term downside risk with possible long-term recovery if management delivers clear commercial progress or a successful financing. Investors should treat CEVE stock as speculative, monitor company filings and market quotes closely, and consider position sizing that reflects extreme volatility and limited information. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts are model-based projections and not guarantees

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.